Safety of Intravenous Immunoglobulin (Tegeline®), Administered at Home in Patients with Autoimmune Disease: Results of a French Study
Table 4
Precautionary measures used to prevent certain adverse events (in average rate, %) (analysis reduced to the patients having taken at least a precautionary measure, ).
Hospital
Home
of patients (%)
(%)
Low-molecular-weight heparin or heparin
12 (38.7)
10 (32.2)
Corticosteroids
12 (38.7)
11 (35.5)
Hydratation before and/or after IVIg infusion (intravenous or oral)
